Department of Neurology, Nanchong Central Hospital; The Second Clinical Medical School, North Sichuan Medical College, Nanchong, 637000, Sichuan, China.
Department of Neurology, Chengdu second people's hospital, Chengdu, 610015, Sichuan, China.
BMC Neurol. 2021 Mar 27;21(1):137. doi: 10.1186/s12883-021-02168-x.
Pneumonia is related to poor prognosis in acute ischemic stroke (AIS), and its risk might be higher in atrial fibrillation (AF) related AIS with elevated plasma D-dimer. The aim of our study was to investigate the prognostic value of D-dimer for predicting clinical outcome of AF-related AIS with pneumonia.
AF-related AIS patients with pneumonia were prospectively enrolled. Receiver operating characteristic (ROC) curve was used to determine the optimal D-dimer point for 3-month mortality and death/severe disability. The associations between the D-dimer and 3-month mortality and death/severe disability were assessed by multivariable logistic regression analysis.
A total of 415 patients were enrolled in this study. ROC curve analysis showed that the optimal cut point of D-dimer for 3-month death/severe disability and mortality were D-dimer≥2.35 mg/l and D-dimer≥3.35 mg/l, respectively. Multivariable logistic regression analysis showed that D-dimer≥2.35 mg/l [adjusted odds ratio (aOR) 5.99, 95% confidence interval (CI): 3.04-11.83, P<0.001], higher NIHISS score (aOR:1.53, 95% CI: 1.38-1.69, P<0.001) and larger infarct volume (aOR 1.01, 95% CI: 1.01-1.02, P<0.001) were associated with increased risk of 3-month death/severe disability), and anticoagulant was associated with decreased risk of death/severe disability (aOR:0.21, 95% CI: 0.09-0.47, P<0.001). Higher NIHISS score (aOR:1.64, 95% CI: 1.38-1.94, P<0.001), older age (aOR 1.08, 95% CI: 1.02-1.14, P = 0.007), D-dimer≥3.35 mg/l (OR 8.49, 95% CI: 4.13-17.84,P<0.001), larger infarct volume (aOR 1.02, 95% CI: 1.00-1.03, P = 0.014), and higher CRUB-65 score (aOR 6.43, 95% CI: 3.10-13.34, P<0.001) were associated with increased risk of 3-month mortality.
AF-related AIS patients with concurrent high D-dimer and pneumonia increased risk of 3-month mortality and death/severe disability, plasma D-dimer may have predictive value in outcome after AF-related AIS with pneumonia.
肺炎与急性缺血性脑卒中(AIS)的预后不良有关,在伴有升高的血浆 D-二聚体的房颤(AF)相关 AIS 中,其风险可能更高。本研究的目的是探讨 D-二聚体预测伴肺炎的 AF 相关 AIS 临床转归的预后价值。
前瞻性纳入伴肺炎的 AF 相关 AIS 患者。采用受试者工作特征(ROC)曲线确定 3 个月死亡率和死亡/严重残疾的最佳 D-二聚体点。多变量 logistic 回归分析评估 D-二聚体与 3 个月死亡率和死亡/严重残疾之间的相关性。
本研究共纳入 415 例患者。ROC 曲线分析显示,D-二聚体预测 3 个月死亡/严重残疾和死亡率的最佳截断值分别为 D-二聚体≥2.35mg/L 和 D-二聚体≥3.35mg/L。多变量 logistic 回归分析显示,D-二聚体≥2.35mg/L[调整后的优势比(aOR)为 5.99,95%置信区间(CI)为 3.04-11.83,P<0.001]、较高的 NIHISS 评分(aOR:1.53,95%CI:1.38-1.69,P<0.001)和更大的梗死体积(aOR 1.01,95%CI:1.01-1.02,P<0.001)与 3 个月死亡/严重残疾风险增加相关,而抗凝与死亡/严重残疾风险降低相关(aOR:0.21,95%CI:0.09-0.47,P<0.001)。较高的 NIHISS 评分(aOR:1.64,95%CI:1.38-1.94,P<0.001)、年龄较大(aOR:1.08,95%CI:1.02-1.14,P=0.007)、D-二聚体≥3.35mg/L(OR:8.49,95%CI:4.13-17.84,P<0.001)、较大的梗死体积(aOR:1.02,95%CI:1.00-1.03,P=0.014)和较高的 CRUB-65 评分(aOR:6.43,95%CI:3.10-13.34,P<0.001)与 3 个月死亡率增加相关。
伴有高 D-二聚体和肺炎的 AF 相关 AIS 患者 3 个月死亡率和死亡/严重残疾风险增加,血浆 D-二聚体可能对伴肺炎的 AF 相关 AIS 的预后有预测价值。